Anna M. Riccio
Genoa, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 36 publications
Targeting the neutrophil-DPP-1-protease axis in airway disease: current evidence and future indications.
Journal: Respiratory medicine
Published: April 21, 2026
The PEACE-24 study: Tezepelumab improves exercise tolerance and symptoms control in severe asthma.
Journal: Respiratory medicine
Published: February 26, 2026
Silent invaders: the role of MPs on epithelium inflammation and damage in airway diseases.
Journal: Frontiers in allergy
Published: December 02, 2025
Connecting the Airways: Current Trends in United Airway Diseases.
Journal: Journal of personalized medicine
Published: November 08, 2025
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy.
Journal: International journal of molecular sciences
Published: February 20, 2024
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD.
Journal: Respiratory research
Published: December 19, 2023
Moderate asthma: burden, mechanisms and therapeutic perspectives.
Journal: Current opinion in allergy and clinical immunology
Published: October 25, 2023
Long-Term Efficacy of Mepolizumab at 3 Years in Patients with Severe Asthma: Comparison with Clinical Trials and Super Responders.
Journal: Biomedicines
Published: May 11, 2023
Nasal cytology as a reliable non-invasive procedure to phenotype patients with type 2 chronic rhinosinusitis with nasal polyps.
Journal: The World Allergy Organization journal
Published: January 28, 2022
Severe asthma: One disease and multiple definitions.
Journal: The World Allergy Organization journal
Published: May 20, 2021
In Vitro Reduction of Interleukin-8 Response to Enterococcus faecalis by Escherichia coli Strains Isolated from the Same Polymicrobial Urines.
Journal: Microorganisms
Published: May 12, 2021
Last Updated: 09/26/2026